Cargando…

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities

Treatment of pediatric-onset multiple sclerosis (POMS) has been tailored after observational studies and data obtained from clinical trials in adult-onset multiple sclerosis (AOMS) patients. There are an increasing number of new therapeutic agents for AOMS, and many will be formally studied for use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Margoni, Monica, Rinaldi, Francesca, Perini, Paola, Gallo, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165183/ https://www.ncbi.nlm.nih.gov/pubmed/34079516 http://dx.doi.org/10.3389/fneur.2021.676095

Ejemplares similares

Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2019)

Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study
por: Riccardi, Alice, et al.
Publicado: (2021)

Predicting Multiple Sclerosis: Challenges and Opportunities
por: Hone, Luke, et al.
Publicado: (2022)

Early red nucleus atrophy in relapse‐onset multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2020)

Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic
por: Margoni, Monica, et al.
Publicado: (2020)

The State of the Art of Pediatric Multiple Sclerosis
por: Teleanu, Raluca Ioana, et al.
Publicado: (2023)

Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis
por: Puthenparampil, Marco, et al.
Publicado: (2023)

Early-Onset Multiple Sclerosis With Frequent Relapses: A Challenging Diagnosis With a Less Favorable Prognosis
por: Thadchanamoorthy, Vijayakumary, et al.
Publicado: (2021)

Preventing Multiple Sclerosis: The Pediatric Perspective
por: Hardy, Duriel, et al.
Publicado: (2022)

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
por: Moiola, Lucia, et al.
Publicado: (2022)

Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis
por: Liu, Joshua, et al.
Publicado: (2022)

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset
por: Tao, Chunrong, et al.
Publicado: (2018)

Editorial: Pediatric TBI - Current State of the Art and Future Perspective
por: Rostami, Elham, et al.
Publicado: (2021)

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors
por: Ajdacic-Gross, Vladeta, et al.
Publicado: (2021)

Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis
por: Pengo, Marta, et al.
Publicado: (2022)

Mobile Attention Bias Modification Training Is a Digital Health Solution for Managing Distress in Multiple Sclerosis: A Pilot Study in Pediatric Onset
por: Charvet, Leigh, et al.
Publicado: (2021)

Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon
por: Puthenparampil, Marco, et al.
Publicado: (2017)

Opportunities and Obstacles Associated With Sequential Immune Reconstitution Therapy for Multiple Sclerosis: A Case Report
por: Garbo, Riccardo, et al.
Publicado: (2021)

D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability
por: Riccardi, Alice, et al.
Publicado: (2019)

Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2018)

Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?
por: Mirabella, Massimiliano, et al.
Publicado: (2022)

Multiple challenges for people after transitioning to secondary progressive multiple sclerosis: a qualitative study
por: Bogosian, Angeliki, et al.
Publicado: (2019)

Cranial Nerve Enhancement in Multiple Sclerosis Is Associated With Younger Age at Onset and More Severe Disease
por: Haider, Lukas, et al.
Publicado: (2019)

SeXX Matters in Multiple Sclerosis
por: Gilli, Francesca, et al.
Publicado: (2020)

Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis
por: Miscioscia, Alessandro, et al.
Publicado: (2022)

Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects
por: Lupica, Antonino, et al.
Publicado: (2022)

Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study
por: Rinaldi, Francesca, et al.
Publicado: (2015)

Sexual Dysfunction in Multiple Sclerosis: The Role of Executive Function
por: Marinetto, Silvia, et al.
Publicado: (2023)

Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis
por: Faizy, Tobias D., et al.
Publicado: (2019)

A wearable device for at-home obstructive sleep apnea assessment: State-of-the-art and research challenges
por: Tran, Ngoc Thai, et al.
Publicado: (2023)

Diagnostic Challenges and Radiological Spectrum of Tumefactive Multiple Sclerosis: A Case Report Study
por: Muddassir, Rabia, et al.
Publicado: (2022)

Interval Timing in Pediatric Multiple Sclerosis: Impaired in the Subsecond Range but Unimpaired in the One-Second Range
por: Troche, Stefan J., et al.
Publicado: (2020)

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
por: Alroughani, Raed, et al.
Publicado: (2021)

Opinion: The role of the registered dietitian nutritionist in multiple sclerosis care in the United States
por: Titcomb, Tyler J., et al.
Publicado: (2023)

The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
por: Kilzheimer, Alexander, et al.
Publicado: (2019)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Memory Impairment in Relapsing-Remitting Multiple Sclerosis Using a Challenging Semantic Interference Task
por: Matias-Guiu, Jordi A., et al.
Publicado: (2020)

New Onset Multiple Sclerosis Post-COVID-19 Vaccination and Correlation With Possible Predictors in a Case-Control Study
por: Alluqmani, Majed
Publicado: (2023)

Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
por: Maffezzini, Sabrina, et al.
Publicado: (2023)

Tele-Neuro-Rehabilitation in Italy: State of the Art and Future Perspectives
por: Maresca, Giuseppa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oj6jorvufsul11q97ek45r578a